Literature DB >> 24712014

Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.

Arturo Cortes-Telles, Lutz Forkert, Denis E O'Donnell, Onofre Moran-Mendoza.   

Abstract

BACKGROUND: The lung function of patients with idiopathic pulmonary fibrosis (IPF) has not been characterized in detail. objective: To characterize the heterogeneous physiological abnormalities that exist in patients with IPF during their initial clinical evaluation.
METHODS: Lung function tests from 93 patients, performed within six months of the initial diagnosis of IPF, were obtained from a referral pulmonary function laboratory at a tertiary care hospital in Canada. A restrictive pattern was defined as total lung capacity (TLC) <95th percentile of predicted value. Patients with obstructive lung disease, lung cancer, emphysema and other restrictive lung diseases were excluded.
RESULTS: On diagnosis, 73% of patients with IPF had a restrictive pattern, with a mean TLC of 72% of predicted. Mean forced vital capacity (FVC) was 71% and 44% of patients had an FVC <95th percentile. Mean diffusing capacity for carbon monoxide (DLCO) was 60% and DLCO⁄alveolar volume (VA) 92% of predicted. Increased severity of restriction - based on TLC - was associated with lower DLCO (74% of predicted in mild restriction and 39% of predicted in severe restriction) and higher forced expiratory volume in 1 s (FEV1)⁄FVC ratio (82% of predicted in mild restriction and 90% of predicted in severe restriction) but not with age (76 years in mild restriction and 69 years in severe restriction). Regardless of severity of restriction, the average DLCO⁄VA (≥86% of predicted) remained within normal limits.
CONCLUSIONS: One in four patients with IPF had normal TLC and more than one-half had a normal FVC during initial evaluation. As the severity of the restriction increased, FEV1⁄FVC increased, DLCO decreased but DLCO⁄VA remained normal.

Entities:  

Mesh:

Year:  2014        PMID: 24712014      PMCID: PMC4128468          DOI: 10.1155/2014/825606

Source DB:  PubMed          Journal:  Can Respir J        ISSN: 1198-2241            Impact factor:   2.409


  30 in total

1.  Respiratory function tests; normal values at median altitudes and the prediction of normal results.

Authors:  H I GOLDMAN; M R BECKLAKE
Journal:  Am Rev Tuberc       Date:  1959-04

2.  The relationship between airway resistance, airway conductance and lung volume in subjects of different age and body size.

Authors:  W A BRISCOE; A B DUBOIS
Journal:  J Clin Invest       Date:  1958-09       Impact factor: 14.808

3.  Interpretative strategies for lung function tests.

Authors:  R Pellegrino; G Viegi; V Brusasco; R O Crapo; F Burgos; R Casaburi; A Coates; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D C Johnson; N MacIntyre; R McKay; M R Miller; D Navajas; O F Pedersen; J Wanger
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

Review 4.  Standardisation of the measurement of lung volumes.

Authors:  J Wanger; J L Clausen; A Coates; O F Pedersen; V Brusasco; F Burgos; R Casaburi; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; J Hankinson; R Jensen; D Johnson; N Macintyre; R McKay; M R Miller; D Navajas; R Pellegrino; G Viegi
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

5.  Idiopathic pulmonary fibrosis: predicting response to therapy and survival.

Authors:  S E Gay; E A Kazerooni; G B Toews; J P Lynch; B H Gross; P N Cascade; D L Spizarny; A Flint; M A Schork; R I Whyte; J Popovich; R Hyzy; F J Martinez
Journal:  Am J Respir Crit Care Med       Date:  1998-04       Impact factor: 21.405

6.  Lung and chest wall mechanics in ventilated patients with end stage idiopathic pulmonary fibrosis.

Authors:  S Nava; F Rubini
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

7.  Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

Authors:  Arata Azuma; Toshihiro Nukiwa; Eiyasu Tsuboi; Moritaka Suga; Shosaku Abe; Koichiro Nakata; Yoshio Taguchi; Sonoko Nagai; Harumi Itoh; Motoharu Ohi; Atsuhiko Sato; Shoji Kudoh
Journal:  Am J Respir Crit Care Med       Date:  2005-01-21       Impact factor: 21.405

8.  Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

Authors:  Yangjin Jegal; Dong Soon Kim; Tae Sun Shim; Chae-Man Lim; Sang Do Lee; Younsuck Koh; Woo Sung Kim; Won Dong Kim; Jin Seong Lee; William D Travis; Masanori Kitaichi; Thomas V Colby
Journal:  Am J Respir Crit Care Med       Date:  2005-01-07       Impact factor: 21.405

9.  Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.

Authors:  Craig E Daniels; Joseph A Lasky; Andrew H Limper; Kathleen Mieras; Edith Gabor; Darrell R Schroeder
Journal:  Am J Respir Crit Care Med       Date:  2009-12-10       Impact factor: 21.405

10.  Reference spirometric values using techniques and equipment that meet ATS recommendations.

Authors:  R O Crapo; A H Morris; R M Gardner
Journal:  Am Rev Respir Dis       Date:  1981-06
View more
  9 in total

1.  Obstructive lung function decline and IPF: The dark face of the moon.

Authors:  Mauro Carone; Francesco G Salerno; Antonio M Esquinas
Journal:  Chron Respir Dis       Date:  2016-02-01       Impact factor: 2.444

2.  Obstructive lung function in idiopathic pulmonary fibrosis.

Authors:  Osamu Nishiyama; Yuji Tohda
Journal:  Chron Respir Dis       Date:  2016-02-09       Impact factor: 2.444

3.  Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema.

Authors:  Yuji Yamamoto; Haruhiko Hirata; Takayuki Shiroyama; Tomoki Kuge; Kinnosuke Matsumoto; Midori Yoneda; Makoto Yamamoto; Yujiro Naito; Yasuhiko Suga; Kiyoharu Fukushima; Kotaro Miyake; Shohei Koyama; Kota Iwahori; Izumi Nagatomo; Yoshito Takeda; Atsushi Kumanogoh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-07-01

4.  Air pollution enhance the progression of restrictive lung function impairment and diffusion capacity reduction: an elderly cohort study.

Authors:  Chi-Hsien Chen; Chih-Da Wu; Ya Ling Lee; Kang-Yun Lee; Wen-Yi Lin; Jih-I Yeh; Hsing-Chun Chen; Yue-Liang Leon Guo
Journal:  Respir Res       Date:  2022-07-14

5.  Interstitial pneumonia associated to peginterferon alpha-2a: A focus on lung function.

Authors:  Arturo Cortés-Telles
Journal:  Lung India       Date:  2016 Mar-Apr

Review 6.  Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.

Authors:  Denis E O'Donnell; Amany F Elbehairy; Danilo C Berton; Nicolle J Domnik; J Alberto Neder
Journal:  Front Physiol       Date:  2017-02-22       Impact factor: 4.566

7.  Near-normal aerobic capacity in long-term survivors after lung transplantation.

Authors:  Berta Saez-Gimenez; Miriam Barrecheguren; Maria Antònia Ramon; Alba Gomez-Garrido; Carlos Bravo; Víctor Monforte; Manuel López-Meseguer; Cristina Berastegui; Eva Revilla; Christian Romero; Rosalía Laporta; Sonia Fernández-Rozas; Javier Redel-Montero; Amparo Solé; Mercedes de la Torre; Luis Puente; Antonio Roman; Susana Gómez-Ollés; Iñigo Ojanguren
Journal:  ERJ Open Res       Date:  2021-02-01

8.  Oscillometry and computed tomography findings in patients with idiopathic pulmonary fibrosis.

Authors:  Yuji Yamamoto; Keisuke Miki; Kazuyuki Tsujino; Tomoki Kuge; Fukuko Okabe; Takahiro Kawasaki; Takanori Matsuki; Hiroyuki Kagawa; Mari Miki; Hiroshi Kida
Journal:  ERJ Open Res       Date:  2020-12-14

9.  Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study.

Authors:  Wen-Jui Wu; Wei-Ming Huang; Chia-Hao Liang; Chun-Ho Yun
Journal:  BMC Med Imaging       Date:  2022-04-23       Impact factor: 2.795

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.